What is uncoupling in Heart Failure with preserved Ejection Fraction (HFpEF)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Uncoupling in HFpEF: Right Ventricular-Pulmonary Arterial Dysfunction

Uncoupling in HFpEF refers to right ventricular-pulmonary arterial (RV-PA) uncoupling, a pathophysiologic state where the right ventricle fails to adequately match its contractile function to the increased pulmonary vascular load, measured as a decreased ratio of end-systolic elastance (Ees) to effective arterial elastance (Ea). 1

Definition and Measurement

RV-PA uncoupling is quantified as an Ees/Ea ratio, with values below normal indicating mismatch between RV contractility and afterload. 1 A practical clinical surrogate is the TAPSE/PASP ratio, where values <0.46 mm/mm Hg indicate RV-PA uncoupling. 2

Mechanisms of Uncoupling in HFpEF

The development of RV-PA uncoupling in HFpEF involves two distinct pathophysiologic processes:

Pulmonary Vascular Dysfunction

  • Increased RV pulsatile afterload is the primary driver of resting and dynamic RV-PA uncoupling in HFpEF, rather than resistive afterload alone. 1
  • Pulmonary hypertension occurs in 52-83% of HFpEF patients, contributing significantly to RV dysfunction. 3
  • Abnormal characteristic pulmonary impedance (ZC) during exercise correlates negatively with Ees/Ea ratio in HFpEF patients (slope -0.96, r²=0.18, P<0.0001), indicating that abnormal pulsatile hemodynamics drive RV failure. 4

Intrinsic RV Contractile Impairment

  • HFpEF patients with abnormal pulmonary vascular response during exercise demonstrate markedly reduced exercise-induced increase in Ees, resulting in decreased Ees/Ea and frank RV-PA uncoupling. 1
  • Even HFpEF patients with normal pulmonary vascular resistance show decreased Ees/Ea during exercise despite preserved Ees response, indicating partially preserved but insufficient RV contractile reserve. 1

Clinical Manifestations and Exercise Physiology

RV-PA uncoupling worsens dynamically during exercise in HFpEF, particularly when increased resistive afterload compounds the baseline pulsatile afterload elevation. 1

Key exercise findings include:

  • Markedly decreased peak oxygen consumption (VO₂) in both uncoupled and coupled HFpEF patients 1
  • Decreased oxygen delivery and impaired chronotropic response 1
  • Lower pulmonary artery compliance and stroke volume in patients with exercise-induced decrease in Ees/Ea 1

Prognostic Significance

Among HFpEF patients with RV-PA uncoupling (TAPSE/PASP <0.46), larger RV dimension (RVD) carries additional prognostic importance for cardiac mortality and HF readmission. 2 In a multicenter cohort of 288 RV-PA uncoupled HFpEF patients, RVD was independently prognostic (HR 1.036,95% CI 1.001-1.072, P=0.0438) after adjusting for age, atrial fibrillation, renal function, and NT-proBNP. 2

Relationship to Vascular Stiffening

Vascular stiffening contributes to ventricular-vascular uncoupling in aged HFpEF patients, with autophagy-mediated vascular senescence potentially playing a mechanistic role. 5 This represents a broader concept of uncoupling beyond just RV-PA relationships, encompassing left ventricular-arterial coupling as well. 5

Clinical Implications

The presence of RV-PA uncoupling helps explain why:

  • Reduced arteriovenous O₂ difference accounts for >50% of the reduction in peak VO₂ in HFpEF and is a stronger independent predictor than exercise cardiac output. 3
  • Standard steady-state hemodynamic metrics (like pulmonary vascular resistance) may appear normal despite significant functional impairment 4
  • Exercise intolerance in HFpEF involves both cardiac and extracardiac mechanisms, consistent with HFpEF being a systemic syndrome 3

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.